CID 162772363

Flezurafenib

Structural Information

Molecular Formula
C26H21FN4O3
SMILES
C1CC(=O)NC2=NC=CC(=C21)OC3=CC4=C(C=C3)OC[C@@H](C4)C5=NC=C(N5)C6=CC=C(C=C6)F
InChI
InChI=1S/C26H21FN4O3/c27-18-3-1-15(2-4-18)21-13-29-25(30-21)17-11-16-12-19(5-7-22(16)33-14-17)34-23-9-10-28-26-20(23)6-8-24(32)31-26/h1-5,7,9-10,12-13,17H,6,8,11,14H2,(H,29,30)(H,28,31,32)/t17-/m1/s1
InChIKey
TWJSMWXWCWQPRO-QGZVFWFLSA-N
Compound name
5-[[(3S)-3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

9
Patents

456.15976 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 457.16704 209.6
[M+Na]+ 479.14898 216.2
[M-H]- 455.15248 215.1
[M+NH4]+ 474.19358 212.4
[M+K]+ 495.12292 207.6
[M+H-H2O]+ 439.15702 195.2
[M+HCOO]- 501.15796 216.5
[M+CH3COO]- 515.17361 214.9
[M+Na-2H]- 477.13443 208.6
[M]+ 456.15921 203.7
[M]- 456.16031 203.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe